CytoSorbents opens regional sales subsidiary in Dubai

CytoSorbents (CTSO) announced the opening of a new regional sales subsidiary in Dubai, United Arab Emirates. The new subsidiary provides a gateway into the Middle East and Africa – regions with increasing demand for advanced medical technologies and high-quality therapies in critical care and cardiac surgery. CytoSorbents has established its new commercial office in the heart of Dubai’s Science Park, a commercial, healthcare-focused, “free zone” with special economic benefits, that will serve as a hub for regional sales and business development, training, customer support, and regulatory affairs. The UAE is the regional home of many multinational medical device companies and was selected because of its strategic location, strong economy and favorable tax policies, advanced infrastructure, well-developed healthcare system, and supportive economic and regulatory policies.